Non hemorrhagic pericardial effusion from ibrutinib İn a patient without comorbidities
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/10781552211073885
Abstract: Introduction The most common kind of leukemia in adults is chronic lymphocytic leukemia (CLL). CLL is treated with ibrutinib. During the course of ibrutinib therapy, bleeding and cardiac arrhythmias may occur. Non-hemorrhagic adverse events are… read more here.
Keywords: non hemorrhagic; effusion; pericardial effusion; ibrutinib patient ... See more keywords